Supplementary Figure 1: In vivo kinetics of roGFP1_R12 oxidation and recovery.
To determine the sensor's kinetics in response to oxidation (diamide) and recovery from that treatment, we acquired OxD roGFP time courses from the pm3 muscles of 10 animals imaged for 10 minutes before treatment, shifted to 50 mM diamide for 60 minutes (oxidation phase; red background), and then shifted back to normal conditions for an additional 60 minutes (recovery phase). Images were acquired once a minute, with a 3 (4) minute operational gap when an animal was first exposed to (or removed from) diamide. Each animal's OxD roGFP time course is colored by the average value of OxD roGFP (baseline) before diamide treatment. The average time for a half-maximal response (t 1/2 ) is less than 1.5 minutes for exposure to oxidant and 4.1 minutes for recovery from oxidant. Cumulative distributions of the sensor's redox potential in the cytosol of feeding muscles in gcs-1(maternal+ zygotic-) animals (red, 49 animals) and their gcs-1(maternal+ zygotic+) siblings (blue, 19 animals). The inset table shows the mean E roGFP values of each group ± one standard error of the mean. Differences in average potential between these two groups were significant (p = 0.01, Wilcoxon Exact test). Cumulative distributions of the sensor's redox potential in multiple transgenic lines expressing the roGFP1_R12 sensor in the cytosol of pharyngeal muscles (green lines), PLM touch neurons (red lines), and intestine (orange lines). The average redox potentials and population sizes (in parenthesis) were: -272.1 mV (185), -272.0 mV (170), and -272.6 mV (44), respectively, for the ydIs1, ydEx20, and ydEx40 pharyngeal muscle lines; -270.7 mV (78) and -270.6 mV (68) for the ydEx35, and ydEx42 PLM neuronal lines; and -270.0 mV (74), -269.8 mV (61), and -269.2 mV (66), respectively, for the ydEx25, ydEx22, and ydEx24 intestinal lines. All transgenic lines were generated independently, except for ydIs1, which was derived by chromosomal integration of ydEx20. Differences in average potential between tissues were significant (p < 0.05 for all pair-wise comparisons between lines of different tissues, Tukey HSD test). No statistical difference in redox potential was observed between lines expressing the sensor in the same tissue (p > 0.05 for all pair-wise comparisons, Tukey HSD test). (c) Cumulative distributions of sensor's redox potentials for the four muscle segments pm3, pm4, pm5, and pm7. For statistics see Supplementary Table 2a .
Supplementary
(d) Cumulative distributions of the difference in redox potential between pairs of muscle segments. For statistics see Supplementary Table 2b . (a) Scatter-plots of ΔE values between pairs of pharyngeal segments are arranged in a matrix. The pharynx-shaped logos denote the segments to which the redox differences refer. Linear regression fits are shown as solid lines flanked by dashed lines marking the 95% confidence interval of the fit. The regression line is red if p < 0.0001 and blue if p > 0.05 for the correlation coefficient r. Separate mechanisms specify the sensor's redox potential in pm3 and pm7 muscles, since differences in potential between pm3 and pm5 muscles are uncorrelated with differences in potential between pm5 and pm7 muscles.
(b-c) These panels depict the pharyngeal redox potentials E roGFP along the anterior-posterior axis for each of the 394 wild-type animals shown in Fig. 3b . Each profile is the best-fit functional (i.e. continuous) representation of the observed E roGFP values using a B-spline basis (see Supplementary Methods).
In both panels these profiles are registered on pm5, that is, we subtract from each profile the average potential in its pm5 region. In panel b, profiles are colored based on their redox-potential difference between pm3 and pm5 muscles; in panel c, they are colored based on their difference between pm5 and pm7 muscles. The lack of correlation between these two differences (panel a) is evidenced by the random mixing of profiles in the pm7 segment in panel b and the pm3 and pm4 segments in panel c. The e1370 allele contains a point mutation affecting the DAF-2 kinase domain 1 and leads to a strong loss of function. The m579 allele contains a point mutation in the ligand binding domain that causes type A insulin resistance in humans 2, 3 . Both daf-2 alleles exhibit lower values of the sensor's redox potential in feeding muscles than wild-type animals. For statistics see Supplementary Table 3b . Table 3c .
(b) This panel shows the reconstructed average pharyngeal redox profiles of wild type and mutant genotypes, derived using functional regression (as detailed in panel c 
Supplementary Figure 10: Redox dynamics in response to oxidant treatment.
We acquired individual redox time courses in pm3, pm5 and pm7 of 64 animals before and after oxidant treatment. Individuals were observed in the absence of treatment for 10 minutes and subsequently treated with 5 mM tert-butyl hydroperoxide (t-BuOOH) for 60 minutes. Images were acquired every 30 seconds with a 6 minute gap between treatment conditions.
(a) The panels show the dynamics of the sensor's redox potential in three pharyngeal segments after converting the data into a functional representation E(t) using a B-spline basis (see Supplementary Methods). Trajectories are colored based on the average value of the redox potential of the whole tissue in the interval prior to oxidant treatment (Ē b ). Thus, each animal is assigned the same color in all panels. The observed redox potential values of 64 animals were baseline corrected (black dots) and threaded into a continuous trace (blue line) using a B-spline basis (see Supplementary Methods). The shaded blue area represents the point-wise 95% confidence interval for the fit. Exposure to 5 mM t-BuOOH starts at time zero. The collection of graphs, sorted by E b , serves the purpose of conveying the faithful representation achieved by functionalizing the data points. 
b) Effect of daf-2 alleles e1370 and m579 on the cytosolic redox potentials of pharyngeal muscle segments The interpretation of the physiological significance of the redox potential reported by the roGFP1_R12 probe requires understanding with which cellular redox couples it can interact in vivo. In this note, we (a) present the evidence for the specificity of roGFP1_R12 for the glutathione couple (b) discuss the performance of the sensor we used relative to that of the glutaredoxin-coupled sensor grx1-roGFP2, and (c) discuss our rationale for choosing roGFP1_R12 rather than grx1-roGFP2 to probe in vivo redox biology in C. elegans.
Statistical comparisons between genotypes
(a) In vitro, in vivo and structural evidence for roGFP specificity Andreas Meyer's group performed several experiments in vitro demonstrating that the oxidation of the related sensors roGFP1 and roGFP2 is controlled specifically by the glutathione couple in a manner catalyzed by glutaredoxin 4, 5, 6 . They showed in vitro that oxidized roGFP: (i) does not react with NADPH or ascorbate; (ii) is not reduced by recombinant poplar thioredoxin h3 (in conjunction with NADPH and NADPH-dependent thioredoxin reductase) or by protein disulfide isomerase; (iii) reacts very slowly with glutathione; and (iv) reacts very quickly with glutathione upon addition of Arabidopsis thaliana glutaredoxin (t 1/2 ~ 2 minutes). Jakob Winther's group developed a structurally similar rxYPF sensor which shows similar properties to roGFP in vitro: it does not interact with thioredoxin in vivo or in vitro, and is reduced by glutathione in vitro and in vivo only in the presence of glutaredoxin 7 .
Tobias Dick's group unsuccessfully tried to build an roGFP2-based sensor responsive to the thioredoxin couple by coupling roGFP2 to human thioredoxin 8 . Indeed, they concluded that human thioredoxin "refuses to interact with the roGFP2 intramolecular disulfide bond"
6 . The persistent lack of success in building an roGFP based sensor specific to the thioredoxin couple lead Meyer and Dick to model whether this sensor's specificity could be the result of differences in the structural constrains imposed by the reaction mechanisms of the glutaredoxin and thioredoxin enzymes 6 . Their careful structural modeling made them conclude that "it seems unlikely that a working Trx-roGFP redox relay can be created." On the upside, they reasoned that this strengthens the concept that roGFPs "really are highly specific probes for 2GSH/GSSG"
6 .
The Winther group demonstrated in vivo that deletion of the two S. cerevisiae gluataredoxins GRX1 and GRX2 dramatically slows down the response of the rxYPF sensor 7 . This indicates that these enzymes are responsible for the fast kinetics of the sensor in vivo. In Arabidopsis there are more than 30 glutaredoxin-coding genes making a similar experiment unfeasible. The Meyer group provided evidence that the sensor responded to cytosolic glutathione by showing that in the partially GSH-deficient Arabidopsis mutant cad2, which is restricted in the activity of the first and rate limiting GSH biosynthetic enzyme glutamate-cysteine ligase, there is an increase in the roGFP2 fluorescence ratio 4 . Subsequently, the Meyer and Dick groups also found that roGFP2 is almost completely oxidized in a different Arabidopsis mutant with only 5% of wild-type GSH levels 6 . In their outstanding review, Meyer and Dick concluded that "taken together, studies on rxYFP and roGFP strongly support the notion that within cells these proteins communicate with the glutathione redox couple through mediation by endogenous Grxs" 6 .
The spontaneous roGFP1_R12 reduction kinetics we measured in vivo when animals are transferred from 50 mM diamide back to normal conditions are very fast ( Supplementary Fig. 1 , t 1/2 = 4.1 minutes); in fact, they are almost as fast as those observed in vitro in the presence of glutaredoxin by the Meyer and Dick groups 4, 5, 8 . Therefore, these kinetics are consistent with the presence of sufficient levels of glutaredoxin to provide fast catalysis in vivo. We note that the observed rate of sensor reduction upon recovery from diamide treatment is really the composite of several rates. The oxidation of both sensor and glutathione occurs directly by diamide 9 , while the reduction of the sensor requires two glutathione molecules 6, 8 and the reduction of glutathione from glutathione disulfide requires reducing equivalents provided by the NADP + /NADPH couple 10 . As a result, the observed timescale of sensor reduction upon diamide removal depends on the reduction kinetics of both sensor and glutathione. Furthermore, this timescale also depends on the rate of diamide clearance from the cytosol (when animals are shifted to plates lacking this oxidant). Thus, the equilibration between the potentials of the sensor and glutathione couples in vivo must occur on a faster timescale than the observed timescale of sensor reduction upon recovery from diamide treatment.
All the tissues in which we performed measurements with our sensor are known to express glutaredoxins: the pharynx and intestine express GLRX-10 and the nervous system expresses GLRX-21 (ref.
11
). However, there may be additional glutaredoxins expressed in these tissues. In C. elegans there are many (at least five, possibly ten) glutaredoxin-coding genes, making it unfeasible to knock out all of them. To provide additional evidence that roGFP1_R12 responds to in vivo changes in glutathione levels we performed an experiment essentially identical to the Meyer group's cad2 mutant experiment (see main text and Supplementary Fig. 3 ), obtaining similar results.
(b) Comparison of the performance of the roGFP1_R12 and grx1-roGFP2 sensors An roGFP-based sensor that exhibits in vitro fast kinetics of reduction by glutathione was developed by Tobias Dick's group by coupling of human glutaredoxin to roGFP2 (ref. 8 ). In contrast to this grx1-roG-FP sensor, roGFP1 and roGFP2 only become quickly reduced by glutathione in vitro in the presence of exogenous glutaredoxin. Thus, the coupling of grx1 to roGFP2 guarantees that the grx1-roGFP2 sensor will respond quickly to changes in the glutathione redox potential. In vivo, in human HeLa cells, the grx1-roGFP2 sensor responds quickly to the changes in glutathione oxidation caused by a pulse of hydrogen peroxide (t 1/2 ~ 10 seconds) compared to the roGFP2 sensor (t 1/2 ~ 1.5 minutes), whose response kinetics depend on endogenous grx activity 8 . This indicates that the roGFP2 sensor's response kinetics limits the ability to resolve short-lived changes in glutathione redox potential. However, when these cells are unperturbed, both sensors report stable fluorescence ratios 8 that are not statistically different from each other 6 . This indicates that both sensors are measuring the same redox potential under stable environmental conditions in HeLa cells. In unperturbed C. elegans, we observe that the sensor's oxidation exhibits a steady state ( Supplementary Fig. 1,2) , supporting the notion that both roGFP1_R12 and grx1-roGFP2 sensors should be equally good at reporting the baseline redox potential of the glutathione couple in live worms.
(c) Rationale for our choice of roGFP1_R12 over grx1-roGFP2 for in vivo measurements Despite the faster kinetics of the grx1-roGFP2 sensor, we believe that the roGFP1_R12 sensor represents a better choice for our experimental needs. As we have argued above, both sensors are specific for the glutathione couple and they are both well fit for measurements under stable environmental conditions. We believe, however, that there are two important drawbacks to the grx1-coupled sensor. First, the use of this sensor inherently entails the expression at high levels of human glutaredoxin 1. At this point, we do not know whether this could result in significant changes to the normal cellular redox environment in the worm, or to changes to the physiology of the worm. Indeed, the physiological roles of the many C. elegans glutaredoxins are very poorly understood. We therefore believe that caution is warranted, leading us to choose the simpler sensor.
Second, in our studies of redox dynamics upon perturbation with oxidants, we were interested in having a sensor that would reflect the normal kinetics that other proteins may experience. If we had chosen to use the grx1-roGFP2 sensor, we could not have probed how quickly endogenous proteins respond to changes in the state of the glutathione pool precisely because the coupling of roGFP2 to human glutaredoxin 1 speeds up those kinetics. Because the use of roGFP1_R12 does not entail the expression of human grx1, the dynamics we measure with the roGFP1_R12 sensor are likely representative of those of many endogenous proteins (which, like roGFP1_R12, are not attached to glutaredoxins).
